SBIR/STTR Research Award

Peptide-Based Serodiagnostic Test for Cysticercosis

Award identifier d9318fa21658e101c29ed2a4426d54a2ecb37da54da8800c6f7355caa6eb111eAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$136,202

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
IMMUNETICS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The aim of this project will be development of new standardized serological tests for cysticercosis utilizing synthetic and recombinant proteins as antigens. Antigens will be selected from components corresponding to seven diagnostic bands of the CDC Western Blot, which utilizes lentil lectin glycoproteins isolated from parasites derived from infected pigs - currently the most sensitive and specific serological test for detection of antibodies against the larval stage of T. solium. Two types of tests will be developed: a standard microplate ELISA format, and a membrane dipstick test. An innovative immune capture assay technology will be applied for new tests which will amplify the advantages of using pure synthetic and recombinant antigens by further reduction of the non-specific reactions which usually accompany serological tests, and by significant simplification of assay protocols. The quick and simple ELISA test will ideally meet requirements for laboratory testing of multiple samples during seroepidemiological surveys and community-based studies, as well as for diagnosis of cysticercosis infection. The dipstick test will provide a convenient and more cost-effective alternative to the current Western Blot test, and will be suitable for small batch or individual testing in lab or field conditions. Principles of antibody detection which will be implemented in the new tests will provide the possibility to use the same tests on both human and animal samples. Phase 1 of this project includes analysis of synthetic and recombinant protein antigens, identification of shorter immunodominant sequences, synthesis of reagents for ELISA and membrane-based tests, and selection of optimal combinations of antigens and test configurations applicable for testing human and porcine samples. Phase 2 will comprise additional optimization of selected formats, validation using larger panels of human and porcine specimens, and clinical evaluation under field conditions.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.